285 related articles for article (PubMed ID: 9844479)
1. [Active drugs against Pseudomonas aeruginosa and their clinical usefulness].
Gobernado M
Rev Clin Esp; 1998 Sep; 198 Suppl 2():51-61. PubMed ID: 9844479
[No Abstract] [Full Text] [Related]
2. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
3. [Pseudomonas aeruginosa. A pathogenic microbe of current importance].
Bergan T
Tidsskr Nor Laegeforen; 1969 Jun; 89(12):1014-6. PubMed ID: 4979183
[No Abstract] [Full Text] [Related]
4. [Bacteremia, endocarditis and meningitis caused by Pseudomonas aeruginosa].
Cisneros Herreros JM; Cañas García-Otero E; Caballero Granado J; Becerril Carral B
Rev Clin Esp; 1998 Sep; 198 Suppl 2():25-9. PubMed ID: 9844475
[No Abstract] [Full Text] [Related]
5. [Trend of therapy in Pseudomonas aeruginosa infections].
Jannuzzi C; Tassara A
G Mal Infett Parassit; 1971 Nov; 23(11):1051-4. PubMed ID: 5004852
[No Abstract] [Full Text] [Related]
6. [Role of antibiotics in infections due to Pseudomonas aeruginosa].
Výmola F; Jedlicková Z
Cesk Epidemiol Mikrobiol Imunol; 1972 Jul; 21(4):176-81. PubMed ID: 4262242
[No Abstract] [Full Text] [Related]
7. Pseudomonas aeruginosa bloodstream infections: how should we treat them?
van Delden C
Int J Antimicrob Agents; 2007 Nov; 30 Suppl 1():S71-5. PubMed ID: 17698326
[TBL] [Abstract][Full Text] [Related]
8. Impact of AmpC overexpression on outcomes of patients with Pseudomonas aeruginosa bacteremia.
Tam VH; Chang KT; Schilling AN; LaRocco MT; Genty LO; Garey KW
Diagn Microbiol Infect Dis; 2009 Mar; 63(3):279-85. PubMed ID: 19135330
[TBL] [Abstract][Full Text] [Related]
9. The changing character of infective endocarditis.
Quinn EL; Burch KH; Cox F; Fisher E; Madhavan T
Am Fam Physician; 1975 Mar; 11(3):117-24. PubMed ID: 803764
[TBL] [Abstract][Full Text] [Related]
10. Drug resistant Pseudomonas aeruginosa bacteremia in HIV-infected patients.
Tacconelli E; Tumbarello M; Ventura G; Lucia MB; Caponera S; Cauda R
J Chemother; 1995 Nov; 7 Suppl 4():180-3. PubMed ID: 8904149
[No Abstract] [Full Text] [Related]
11. [Effective agents against Pseudomonas pyocyanea (proceedings)].
Meyer-Rohn J
Z Hautkr; 1976; 51 Suppl 2():106-8. PubMed ID: 827860
[No Abstract] [Full Text] [Related]
12. In vivo efficacy and pharmacokinetics of tomopenem (CS-023), a novel carbapenem, against Pseudomonas aeruginosa in a murine chronic respiratory tract infection model.
Morinaga Y; Yanagihara K; Nakamura S; Yamamoto K; Izumikawa K; Seki M; Kakeya H; Yamamoto Y; Yamada Y; Kohno S; Kamihira S
J Antimicrob Chemother; 2008 Dec; 62(6):1326-31. PubMed ID: 18835805
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Pseudomonas aeruginosa infection.
Eykyn SJ
Br J Hosp Med; 1984 Feb; 31(2):136-40. PubMed ID: 6421353
[No Abstract] [Full Text] [Related]
14. Pseudomonas endocarditis in the Detroit Medical Center. 1969-1972.
Reyes MP; Palutke WA; Wylin RF
Medicine (Baltimore); 1973 May; 52(3):173-94. PubMed ID: 20407410
[No Abstract] [Full Text] [Related]
15. Isolation of an amikacin-resistant Escherichia coli strain after tobramycin treatment of previous recurrent episodes of respiratory tract infections caused by Pseudomonas aeruginosa.
Ruiz J; Bertran S; Sauca G; Julià A; Vila X; Gómez E; Jiménez de Anta MT; Vila J
Clin Microbiol Infect; 2005 Jan; 11(1):71-3. PubMed ID: 15649309
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial resistance and genetic characterization of fluoroquinolone resistance of Pseudomonas aeruginosa isolated from canine infections.
Rubin J; Walker RD; Blickenstaff K; Bodeis-Jones S; Zhao S
Vet Microbiol; 2008 Sep; 131(1-2):164-72. PubMed ID: 18395369
[TBL] [Abstract][Full Text] [Related]
17. [O-serovars and antibiotic sensitivities in strains of Pseudomonas aeruginosa of human and animal origin].
Zschöck M; Schliesser T
Zentralbl Veterinarmed B; 1986 Aug; 33(6):440-6. PubMed ID: 3098000
[No Abstract] [Full Text] [Related]
18. [Chemotherapy of infections caused by Pseudomonas aeruginosa (pyocyanosis)].
Chernomordik AB; Panchenko MK; Bulycheva NP
Klin Med (Mosk); 1982 Jun; 60(6):17-20. PubMed ID: 6811797
[No Abstract] [Full Text] [Related]
19. [Susceptibility patterns of Pseudomonas aeruginosa strains isolated in the Monastir region, Tunisia].
Abdallah HB; Noomen S; Khélifa AB; Sahnoun O; Elargoubi A; Mastouri M
Med Mal Infect; 2008 Oct; 38(10):554-6. PubMed ID: 18814981
[TBL] [Abstract][Full Text] [Related]
20. [Recommendations for the treatment of nosocomial infections caused by Gram-positive microorganisms].
Azanza JR; Barberán J; García-Rodríguez JA; Llinares P; Mensa J; Picazo J; Prieto J; Torre Cisneros J
Rev Esp Quimioter; 2004 Sep; 17(3):271-88. PubMed ID: 15619658
[No Abstract] [Full Text] [Related]
[Next] [New Search]
